Medpace Holdings, Inc.

Medpace Holdings Inc. is a prominent entity in the clinical contract research organization sector, providing comprehensive services essential for the development and commercialization of pharmaceutical products. The company's primary function is to assist biotechnology, pharmaceutical, and medical device companies by managing deep and complex activities essential for conducting clinical trials. Medpace is renowned for its full-service approach, facilitating everything from preclinical studies through to post-marketing approval, ensuring compliance and efficacy at each stage of the drug development process. Operating internationally, Medpace impacts various therapeutic areas, ranging from oncology to cardiovascular and metabolic diseases, among others. Its ability to offer globally standardized services with a focus on efficiency and quality makes it a valuable partner in the increasingly complex and regulated world of drug development. In the financial market, Medpace plays a crucial role by accelerating the entry of new therapies and innovations, aiding in the improvement of public health outcomes, and supporting the continuous growth and dynamism of the life sciences industry. Founded in 1992 and headquartered in Cincinnati, Ohio, Medpace aligns scientific expertise with rigorous process management to drive success for its clients.